AU2001276323A1 - Use of n-oleoylethanolamine for treating psoriasis - Google Patents

Use of n-oleoylethanolamine for treating psoriasis

Info

Publication number
AU2001276323A1
AU2001276323A1 AU2001276323A AU7632301A AU2001276323A1 AU 2001276323 A1 AU2001276323 A1 AU 2001276323A1 AU 2001276323 A AU2001276323 A AU 2001276323A AU 7632301 A AU7632301 A AU 7632301A AU 2001276323 A1 AU2001276323 A1 AU 2001276323A1
Authority
AU
Australia
Prior art keywords
oleoylethanolamine
treating psoriasis
psoriasis
treating
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001276323A
Other languages
English (en)
Inventor
Susanne Grether-Beck
Jean Krutmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GRETHER BECK SUSANNE
Original Assignee
GRETHER BECK SUSANNE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GRETHER BECK SUSANNE filed Critical GRETHER BECK SUSANNE
Publication of AU2001276323A1 publication Critical patent/AU2001276323A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
AU2001276323A 2000-07-29 2001-07-14 Use of n-oleoylethanolamine for treating psoriasis Abandoned AU2001276323A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10037046A DE10037046A1 (de) 2000-07-29 2000-07-29 Verwendung von N-Oleoylethanolamin zur Behandlung der Schuppenflechte (Psoriasis)
DE10037046 2000-07-29
PCT/DE2001/002630 WO2002009687A1 (fr) 2000-07-29 2001-07-14 Utilisation de n-oleylethanolamine pour traiter le psoriasis

Publications (1)

Publication Number Publication Date
AU2001276323A1 true AU2001276323A1 (en) 2002-02-13

Family

ID=7650683

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001276323A Abandoned AU2001276323A1 (en) 2000-07-29 2001-07-14 Use of n-oleoylethanolamine for treating psoriasis

Country Status (5)

Country Link
EP (1) EP1305016B1 (fr)
AT (1) ATE288263T1 (fr)
AU (1) AU2001276323A1 (fr)
DE (2) DE10037046A1 (fr)
WO (1) WO2002009687A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2233128A1 (fr) * 2009-03-25 2010-09-29 Cognis IP Management GmbH Composition cosmétique
KR20150091983A (ko) * 2014-02-04 2015-08-12 (주)네오팜 발모촉진용 또는 탈모방지용 조성물
CN106821781A (zh) * 2017-02-14 2017-06-13 厦门大学 一种皮肤美白化妆组合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506224A (en) * 1991-12-31 1996-04-09 Lifegroup S.P.A. N-acyl derivatives of aminoalcohols active as local autacoids and useful in the therapy of autoimmune processes
EP0606590A1 (fr) * 1992-12-18 1994-07-20 Rhone-Poulenc Rorer Gmbh Composition pharmaceutique et/ou cosmétique contenant des N-acylalcanolamines et des N-acylphospho- ou lysophospholipides
US5830916A (en) * 1996-05-23 1998-11-03 Duke University Inhibitor of ceramidase
IT1296148B1 (it) * 1996-11-22 1999-06-09 Renata Maria Anna Ve Cavaliere Uso di batteri lattici per accrescere il livello delle ceramidi della pelle e delle mucose, e composizioni dermatologiche e cosmetiche atte

Also Published As

Publication number Publication date
EP1305016B1 (fr) 2005-02-02
DE50105253D1 (de) 2005-03-10
DE10037046A1 (de) 2002-02-21
ATE288263T1 (de) 2005-02-15
EP1305016A1 (fr) 2003-05-02
WO2002009687A1 (fr) 2002-02-07

Similar Documents

Publication Publication Date Title
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
MXPA03011515A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
GEP20094798B (en) (s,s)-reboxetine for treating chronic pain
MXPA05008406A (es) Compuestos de amida tri(ciclo)-sustituida.
FI956014A0 (fi) Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon
EE05419B1 (et) Asendatud oksasolidinoonid kombineeritud raviks
PL414996A1 (pl) Zastosowanie 40-O-(2-hydroksyetylo)-rapamycyny do wytwarzania leku do leczenia litych guzów ośrodkowego układu nerwowego
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
MY137435A (en) Retinoid compounds (i)
WO2004073615A3 (fr) Composes de deazaflavine et leurs methodes d'utilisation
GB0020504D0 (en) Therapeutic method
BG105962A (en) Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders
BG101126A (en) The use of muramylpeptide compounds
AU3919001A (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
AU2001276323A1 (en) Use of n-oleoylethanolamine for treating psoriasis
MXPA04000272A (es) Derivados de 4-aminociclohexanol sustituidos.
PL367401A1 (en) Utilization of buprenorphine in urinary incontinence therapy
AU2002319223A1 (en) Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein
UA83017C2 (uk) Комбінація рофлуміласту та r,r-формотеролу для лікування захворювань дихальних шляхів
WO2002038140A3 (fr) Utilisations therapeutiques de modulateurs du canal calcique induits par le recepteur ip¿3?
WO2003029221A8 (fr) Tetrahydroisochinolines, leur preparation et leur utilisation en tant qu'analgesiques
AU2003255429A1 (en) Use of treosulfan and derivatives thereof for treating multiple sclerosis
UA32314A (uk) Спосіб лікування некротичного панкреатиту
UA33498A (uk) Спосіб лікування терапевтично резистентних форм шизофренії